Neoadjuvant Nivolumab, Docetaxel, Cisplatin Therapy Followed by Surgery and Radiation Therapy for Resectable High Grade Salivary Gland Carcinoma
Clinical trial NCT05727410 · RECRUITING
Trial details
- NCT number
- NCT05727410
- Sponsor
- Myung-Ju Ahn
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-15
- Primary completion
- 2026-08-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.